Literature DB >> 4696602

Effect of chronic administration of L-dopa on catechol-O-methyltransferase in rat tissues.

N S Sharpless, G M Tyce, C A Owen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4696602     DOI： 10.1016/0024-3205(73)90367-6

Source DB:  PubMed          Journal:  Life Sci I        ISSN： 0300-9653


× No keyword cloud information.
  4 in total

1.  Binding of exogenous noradrenaline by the proteins of dog plasma.

Authors:  D Branco; J F Torrinha; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

Review 2.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa dose.

Authors:  Helena Heikkinen; Anu Varhe; Tarmo Laine; Jaakko Puttonen; Marjo Kela; Seppo Kaakkola; Kari Reinikainen
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

4.  Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules.

Authors:  P Soares-da-Silva; M H Fernandes; P C Pinto-do-O
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.